vs

Side-by-side financial comparison of BLACKBERRY Ltd (BB) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $141.8M, roughly 1.6× BLACKBERRY Ltd). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 9.7%, a 9.7% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs -0.8%). Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $17.4M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 17.8%).

BlackBerry Limited, formerly Research In Motion (RIM), is a Canadian software company specializing in secure communications and the Internet of Things (IoT). Founded in 1984, it developed the BlackBerry brand of two-way pagers, smartphones, and tablets. The company later transitioned to providing software and services and holds critical software application patents.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

BB vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.6× larger
ORGO
$225.6M
$141.8M
BB
Growing faster (revenue YoY)
ORGO
ORGO
+79.0% gap
ORGO
78.1%
-0.8%
BB
Higher net margin
ORGO
ORGO
9.7% more per $
ORGO
19.4%
9.7%
BB
More free cash flow
ORGO
ORGO
$17.4M more FCF
ORGO
$34.8M
$17.4M
BB
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
17.8%
BB

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
BB
BB
ORGO
ORGO
Revenue
$141.8M
$225.6M
Net Profit
$13.7M
$43.7M
Gross Margin
77.5%
Operating Margin
8.4%
28.1%
Net Margin
9.7%
19.4%
Revenue YoY
-0.8%
78.1%
Net Profit YoY
224.5%
469.5%
EPS (diluted)
$0.02
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BB
BB
ORGO
ORGO
Q4 25
$141.8M
$225.6M
Q3 25
$129.6M
$150.9M
Q2 25
$121.7M
$101.0M
Q1 25
$141.7M
$86.7M
Q4 24
$143.6M
$126.7M
Q3 24
$126.2M
$115.2M
Q2 24
$123.4M
$130.2M
Q1 24
$102.1M
$110.0M
Net Profit
BB
BB
ORGO
ORGO
Q4 25
$13.7M
$43.7M
Q3 25
$13.3M
$21.6M
Q2 25
$1.9M
$-9.4M
Q1 25
$-7.4M
$-18.8M
Q4 24
$-10.5M
$7.7M
Q3 24
$-19.7M
$12.3M
Q2 24
$-41.4M
$-17.0M
Q1 24
$-56.2M
$-2.1M
Gross Margin
BB
BB
ORGO
ORGO
Q4 25
77.5%
Q3 25
74.5%
Q2 25
74.2%
Q1 25
73.5%
72.6%
Q4 24
78.1%
75.5%
Q3 24
70.2%
76.7%
Q2 24
72.9%
77.6%
Q1 24
73.9%
Operating Margin
BB
BB
ORGO
ORGO
Q4 25
8.4%
28.1%
Q3 25
8.9%
13.7%
Q2 25
1.6%
-12.5%
Q1 25
-5.6%
-30.9%
Q4 24
13.6%
8.1%
Q3 24
1.7%
5.4%
Q2 24
-10.5%
-10.7%
Q1 24
50.0%
-3.5%
Net Margin
BB
BB
ORGO
ORGO
Q4 25
9.7%
19.4%
Q3 25
10.3%
14.3%
Q2 25
1.6%
-9.3%
Q1 25
-5.2%
-21.7%
Q4 24
-7.3%
6.1%
Q3 24
-15.6%
10.7%
Q2 24
-33.5%
-13.1%
Q1 24
-55.0%
-1.9%
EPS (diluted)
BB
BB
ORGO
ORGO
Q4 25
$0.02
$0.31
Q3 25
$0.02
$0.11
Q2 25
$0.00
$-0.10
Q1 25
$-0.01
$-0.17
Q4 24
$-0.02
$0.05
Q3 24
$-0.03
$0.09
Q2 24
$-0.07
$-0.13
Q1 24
$-0.08
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BB
BB
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$304.2M
$93.7M
Total DebtLower is stronger
$196.2M
Stockholders' EquityBook value
$741.1M
$300.1M
Total Assets
$1.2B
$598.7M
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BB
BB
ORGO
ORGO
Q4 25
$304.2M
$93.7M
Q3 25
$290.5M
$63.7M
Q2 25
$306.6M
$73.1M
Q1 25
$337.8M
$110.0M
Q4 24
$220.0M
$135.6M
Q3 24
$211.0M
$94.3M
Q2 24
$229.0M
$89.9M
Q1 24
$237.1M
$88.6M
Total Debt
BB
BB
ORGO
ORGO
Q4 25
$196.2M
Q3 25
$195.9M
Q2 25
$195.6M
Q1 25
$195.3M
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$194.1M
$65.2M
Stockholders' Equity
BB
BB
ORGO
ORGO
Q4 25
$741.1M
$300.1M
Q3 25
$725.1M
$255.1M
Q2 25
$725.1M
$233.2M
Q1 25
$719.9M
$242.9M
Q4 24
$725.2M
$262.9M
Q3 24
$732.1M
$278.5M
Q2 24
$742.6M
$263.5M
Q1 24
$775.1M
$278.0M
Total Assets
BB
BB
ORGO
ORGO
Q4 25
$1.2B
$598.7M
Q3 25
$1.2B
$509.8M
Q2 25
$1.2B
$461.1M
Q1 25
$1.3B
$467.4M
Q4 24
$1.3B
$497.9M
Q3 24
$1.3B
$446.3M
Q2 24
$1.3B
$443.2M
Q1 24
$1.4B
$458.5M
Debt / Equity
BB
BB
ORGO
ORGO
Q4 25
0.26×
Q3 25
0.27×
Q2 25
0.27×
Q1 25
0.27×
Q4 24
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.25×
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BB
BB
ORGO
ORGO
Operating Cash FlowLast quarter
$18.3M
$39.4M
Free Cash FlowOCF − Capex
$17.4M
$34.8M
FCF MarginFCF / Revenue
12.3%
15.4%
Capex IntensityCapex / Revenue
0.6%
2.1%
Cash ConversionOCF / Net Profit
1.34×
0.90×
TTM Free Cash FlowTrailing 4 quarters
$42.8M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BB
BB
ORGO
ORGO
Q4 25
$18.3M
$39.4M
Q3 25
$3.9M
$3.1M
Q2 25
$-18.0M
$-32.9M
Q1 25
$41.6M
$-19.9M
Q4 24
$6.0M
$10.9M
Q3 24
$-16.0M
$8.7M
Q2 24
$-15.1M
$4.7M
Q1 24
$-15.5M
$-10.2M
Free Cash Flow
BB
BB
ORGO
ORGO
Q4 25
$17.4M
$34.8M
Q3 25
$3.1M
$844.0K
Q2 25
$-18.9M
$-36.5M
Q1 25
$41.2M
$-23.6M
Q4 24
$5.2M
$7.6M
Q3 24
$-16.5M
$6.1M
Q2 24
$-16.5M
$2.9M
Q1 24
$-17.6M
$-12.4M
FCF Margin
BB
BB
ORGO
ORGO
Q4 25
12.3%
15.4%
Q3 25
2.4%
0.6%
Q2 25
-15.5%
-36.1%
Q1 25
29.1%
-27.2%
Q4 24
3.6%
6.0%
Q3 24
-13.1%
5.3%
Q2 24
-13.4%
2.2%
Q1 24
-17.2%
-11.3%
Capex Intensity
BB
BB
ORGO
ORGO
Q4 25
0.6%
2.1%
Q3 25
0.6%
1.5%
Q2 25
0.7%
3.6%
Q1 25
0.3%
4.2%
Q4 24
0.6%
2.7%
Q3 24
0.4%
2.2%
Q2 24
1.1%
1.4%
Q1 24
2.1%
2.0%
Cash Conversion
BB
BB
ORGO
ORGO
Q4 25
1.34×
0.90×
Q3 25
0.29×
0.14×
Q2 25
-9.47×
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BB
BB

QNX$68.7M48%
Secure Communication$67.0M47%
Licensing$6.1M4%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons